Product image #1 for Wegovy®


  • Injection

The sister treatment to Ozempic® that is specifically approved for weight loss, Wegovy® is a self-injectable semaglutide FDA approved for adults with a BMI of 27 or more.

Starting at $1,695

Start online visit

Wegovy - Do More, Age Less


Do more, age less

  • FDA-approved semaglutide weight loss injectable
  • Accelerates weight loss and helps keep weight off
  • Helps to regulate appetite and caloric intake
  • Ideal for adults with BMI >27 (more than 20lbs to lose)
  • Improves blood pressure and cholesterol levels¹
  • Lowers blood sugar levels¹
  • Use with reduced-calorie meal plan and exercise for best results


Background and history

  • The active ingredient in Wegovy® is semaglutide
  • FDA-approved for weight loss
  • Mimics glucagon-like peptide (GLP-1), a hormone that regulates appetite and food intake
  • Administered once weekly with convenient injectable pen
  • Dosages titrates up over several months for maximum results
  • In a 68-week study, adults lost ~35lbs or 15% body weight²
  • Weight control is a key factor in general longevity
  • Lowering your BMI can help reduce risk of age-related and/or inflammatory diseases
Wegovy Background and History

Is Wegovy® right for you?

First, use our free wellness platform to find out what your BMI is.

Next, find your BMI on the chart below to see if you’re within the indicated range for Wegovy® treatment:

BMIIs Wegovy® Right for Me?*
24.9 or lessNo
25.0 – 26.9Case-by-case**
27.0 – 29.9Likely**
30.0 or aboveLikely

*Your prescriber will approve or disapprove a Wegovy® prescription at their discretion after careful consideration of your unique health profile; approval is not guaranteed based on the above criteria.
**Those with a BMI of 25-29 may be considered on a case-by-case basis after further review for the presence of additional weight-related medical issues.

Gradient background image

Ready to get started?
Start your free online visit now.

In stock
Ozempic – Monthly
$1,350 / month billed monthly | free shipping
  • Ozempic® injection pens

  • FDA approved for type 2 diabetes

  • Same active ingredient as Wegovy® (semaglutide)
  • Doctor-guided titration schedule

  • Dispensed from a certified pharmacy

  • Free and ongoing medical support

FREE medical evaluation

Out of stock
Wegovy – Monthly
$1,695 / month billed monthly | free shipping
  • Wegovy® injection pens

  • New supply sent monthly

  • Doctor-guided titration schedule

  • Dispensed from a certified pharmacy

  • Free and ongoing medical support

FREE medical evaluation

Ozempic® is not available in MS.

You will be automatically billed & sent refills based on your plan

You can pause or cancel at any time before your next shipment

* Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. See below for important safety information. Benefits outlined on are based on 3rd party studies. Medication is offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown. Due to nationwide manufacturing shortages, AgelessRx may elect to prescribe an equivalent GLP-1 product in place of Wegovy® at specific dosages.

How it works


What is Wegovy®?

Wegovy® is an FDA-approved injectable prescription medication to assist adults with BMI >27 lose weight and keep the weight off. The injection comes in the form of a pen for subcutaneous (under the skin) use only.

How often is Wegovy® taken?

You will administer your Wegovy® injection only once per week, at any time of day, with or without food.

Which doses of Wegovy® do you offer?

If you have never used Wegovy® before, you will follow a doctor-guided titration schedule. You will begin with a dose of 0.25mg per injection and, over a period of 4 to 5 months, slowly work up to the maximum 2.4mg per injection.

What’s the difference between Ozempic® and Wegovy®?

Both medications are GLP-1s (glucagon-like receptor agonists) and contain the same active ingredient (semaglutide). Since the two drugs have the same active ingredient, it is fair to ask: is Wegovy® the same as Ozempic®?

Wegovy® and Ozempic® are the same medications, sold under different brand names. The main differences are the amount of semaglutide in each pen (the dosage) and the prescribed use for each, as well as the guided titration schedule: Ozempic® is FDA approved for type 2 diabetes, with a target dosage of 2.0mg, while Wegovy® is FDA approved for weight loss, with a target dosage of 2.4mg.

Ozempic® is considered a safe and reliable alternative for Wegovy®, with many users reporting consistent outcomes. Historically, Ozempic® has also been prescribed when Wegovy® supplies are limited.

See all FAQs

Important safety information and common side effects

Wegovy® should be used with a reduced-calorie meal plan and increased physical activity.
Wegovy® contains semaglutide and should not be used with other GLP-1 receptor agonist medicines, or any other products containing semaglutide.

Most common Wegovy® side effects

The most common side effects of Wegovy® include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder).  

The above is only a summary. For a full list of possible side effects, and other important safety information, click here.

Other important safety information

Wegovy® is FDA approved to treat weight loss in adults with a BMI of 30 or greater. It’s also approved for those with a BMI of 27 or greater, who also have a medical condition caused by their weight. 

Approval for treatment is not guaranteed. Eligibility and approval is always at the discretion of the prescriber, who will determine eligibility based on an assessment of your complete health profile.

Do not use Wegovy® if you are allergic to semaglutide or any of its ingredients.

Do not use Wegovy® if you are currently pregnant, breastfeeding or plan to become pregnant or breastfeed.

Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. 

The above is only a summary. For a full list of important safety information, click here.

Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Wegovy® is an appropriate part of a weight loss plan for you.

¹ Wegovy® is not FDA approved for these uses, however, a 68-week clinical study noted these benefits.